Status:
COMPLETED
Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia
Lead Sponsor:
University Hospital, Limoges
Conditions:
Covid19
Inflammatory Rheumatism
Eligibility:
All Genders
18+ years
Brief Summary
The project proposes to evaluate a strategy for prioritizing teleconsultation for patients with chronic inflammatory rheumatic diseases during the COVID-19 pandemia. This selection will be done throug...
Detailed Description
The COVID-19 pandemic led to the suspension of consultations and hospitalization of the majority of patients followed in the Rheumatology Department of the Limoges University Hospital. The department...
Eligibility Criteria
Inclusion
- Patients with chronic inflammatory rheumatism who answered the RIC-COVID19 survey during the telephone call set up by the Rheumatology Department of the Limoges University Hospital during the confinement.
Exclusion
- Patients objecting to the use of their data
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
918 Patients enrolled
Trial Details
Trial ID
NCT04806867
Start Date
May 1 2020
End Date
July 31 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Rhumatologie, CHu de Limoges
Limoges, France, 87000